|
The Cochrane Collaboration
Cochrane Reviews |
|
|
For complete list (no sub-topics), click here - Browse by sub-topic (Review Group)
Peripheral Vascular Diseases Group
(323)
Aortic aneurysm, abdominal and peripheral aneurysm (16)
Prevention (0)
Treatment (16)
Surgical treatments (pre-, peri- or post-operatively) (12)
Alpha-agonists (0)
Anticoagulants (0)
ACE inhibitors (0)
Analgesics (0)
Antiplatelets (0)
Beta-agonists (0)
Beta-blockers (0)
Blood transfusion (0)
Calcium antagonists (0)
Catecholamines (0)
Cell saver - use of (0)
Cytoprotectants (0)
Cytochromes (factors affecting cytochrome system) (0)
Graft types (1)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
H2 blockers (0)
Haemodilution (0)
Heparin agonists (0)
Hydration - optimal pre-operative (0)
Incision - types of (0)
IV nutrition (0)
Lumbar sympathectomy (0)
Optiate antagonists (0)
Prostaglandins (0)
Pre-operative factors (not drugs or hydration) (0)
Sedatives (0)
Surgical techniques (3)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
Surgery versus non-surgical treatment (3)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
Temperature (0)
Thromboxane antagonists (0)
Vasodilators (0)
Rehabilitation (0)
Acute limb ischaemia (5)
Prevention (0)
Treatment (5)
Surgical treatments (4)
Amputations (2)
Criteria for determining level of amputation (0)
Treatments given pre-, peri- or post-operatively (including following list to 'Vasodilators') (0)
Analgesics (0)
Anaesthetics (0)
Antibiotics (0)
Antipsychotics (0)
Antiplatelets (0)
Compression dressings (0)
Dressings (0)
Electromyostimulation (0)
Fibrinolytics (0)
Prostaglandins (0)
Phototherapy (0)
Vasodilators (0)
Anaesthetics used during surgery (0)
Surgical revascularisation (0)
Drugs used during surgical thrombectomy (0)
Amputation (2)
Prevention (0)
Critical limb ischaemia (45)
Prevention (0)
Treatment (45)
Medical treatments (5)
Amino acids (0)
Anticoagulants (0)
Analgesics (0)
Antibiotics (0)
Antiplatelets (1)
Sarpogrelate for peripheral arterial disease (protocol stage)
Buflomedil (0)
Dextran (0)
Haemodialysate (0)
Energy rich phosphates (0)
Fibrinolytics (0)
Gene therapy (0)
Herbal preparations (0)
Metabolic activators (0)
Methyl xanthines (0)
Prostaglandins (1)
Prostanoids for critical limb ischemia (protocol stage)
Pentoxifylline (0)
Rutosides (0)
Serotonin antagonists (0)
Stem cell transplantation (0)
Thromboxane antagonists (0)
Vasodilators (0)
Vasospastic agents (0)
Surgical treatment (37)
Amputation (see 'Acute limb ischaemia' for details) (0)
Angioplasty (24)
Antibiotics (0)
Antiplatelets (0)
Buflomedil (0)
Haemostatic devices (0)
Oxygen supplementation (0)
Pre-operative drugs (0)
Prostaglandins (0)
Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)
Atherectomy for peripheral arterial disease (protocol stage)
Balloon dilatation (5)
Atherectomy for peripheral arterial disease (protocol stage)
Closure techniques (0)
Laser recanalisation (1)
Atherectomy for peripheral arterial disease (protocol stage)
Guide wires (0)
Angipolasty versus other surgical techniques (4)
Atherectomy for peripheral arterial disease (protocol stage)
Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (0)
Anticoagulants (1)
Anaesthetics (0)
Antiplatelets (1)
Dextran (0)
Essential fatty acids (0)
Haemodilution (0)
Lipid lowering (0)
Atherectomy (including endarterectomy and thromboendarterectomy) (2)
Atherectomy for peripheral arterial disease (protocol stage)
Bypass surgery (2)
Interposition vein cuff for infragenicular prosthetic bypass graft (protocol stage)
Stent insertion (4)
Atherectomy for peripheral arterial disease (protocol stage)
Surgical technique (1)
Interposition vein cuff for infragenicular prosthetic bypass graft (protocol stage)
Sympathectomy (1)
Sympathectomy for peripheral arterial disease (protocol stage)
Rehabilitation (0)
Chronic venous insufficiency (9)
Prevention (3)
Compression (1)
Prevention of venous insufficiency in a standing workers population (protocol stage)
Exercise (1)
Prevention of venous insufficiency in a standing workers population (protocol stage)
Treatment (6)
Medical treatments (5)
Anticoagulants (0)
Calcium antagonists (0)
Fibrinolytics (0)
Non-steroidal anti-inflammatories (0)
Rheological agents (0)
Ruscus extracts (0)
Steroids (0)
Thrombolytics (0)
Topical treatments (0)
Rehabilitation (0)
Oedema (0)
Prevention (0)
Treatment (0)
Medical treatments (0)
Bradykinin antagonists (0)
Diuretics (0)
Herbal preparations (0)
Rutosides (0)
Saccharides (0)
Steroids (0)
Venoactive agents (0)
Rehablitation (0)
Peripheral arterial occlusive disease (PAOD) (80)
Prevention (0)
Treatment (80)
Medical treatments (28)
Amino acids (0)
Alpha blockers (0)
Angiogenesis (0)
Anticoagulants (2)
ACE inhibitors (0)
Alcohol (0)
Antiplatelets (4)
Antiplatelet agents for intermittent claudication (protocol stage)
Sarpogrelate for peripheral arterial disease (protocol stage)
Bamethane sulphate (0)
Bradykin antagonists (0)
Beta-blockers (2)
Biguanides (0)
Blood pressure lowering drugs (0)
Calcium antagonists (0)
Calcitonin (0)
Cerebral activator agents (0)
Chemical sympathectomy (0)
Carbon dioxide (0)
Co-enzymes for vitamins (0)
Cytochromics (0)
Depropanox (0)
Dextran (0)
Energy rich phosphates (0)
Fibrinolytics (2)
Fibrinolytic agents for peripheral arterial occlusion (protocol stage)
Gene therapy (1)
Gene therapy for peripheral arterial disease (protocol stage)
Glucose metabolites (0)
Haemodialysate (0)
Haemodilution (0)
Herbal preparations (3)
Padma 28 for intermittent claudication (protocol stage)
Hypoglycaemic agents (oral) (0)
Ifenprodil (0)
Lipid lowering (2)
Monoamine oxidase inhibitors (0)
Methyl blue (0)
Methyldopa (0)
Methyl xanthine (0)
Narcain antagonists (0)
Nerve block (0)
Neuroleptics (0)
Oestrogens (0)
Oxygen supplementation (0)
Ozone treatment (0)
Pantetheine (0)
Prostaglandins (2)
Pentoxifylline (2)
Pentoxifylline for intermittent claudication (protocol stage)
Rheological agents (0)
Rutosides (0)
Serotonin antagonists (0)
Suphonylurea (0)
Topical treatments (0)
Trace elements (0)
Thromboxane antagonists (0)
Vasodilators (0)
Vasospastic agents (0)
Physical treatments (0)
Electromagnetic field (diapulse) (0)
Electromyostimulation (0)
Immersion therapy (0)
Massage treatment (0)
Intermittent suction pressure treatment (0)
Surgical treatments (41)
Angioplasty (see 'Critical limb ischaemia' for details) (21)
Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)
Atherectomy for peripheral arterial disease (protocol stage)
Balloon dilatation (6)
Atherectomy for peripheral arterial disease (protocol stage)
Angioplasty versus other surgical techniques (5)
Atherectomy for peripheral arterial disease (protocol stage)
Anticoagulants (1)
Antiplatelets (1)
Atherectomy (including endarterectomy and thromboendarterectomy) (2)
Atherectomy for peripheral arterial disease (protocol stage)
Bypass surgery (10)
Anticoagulants (1)
ACE inhibitors (0)
Anaesthesia (0)
Analgesics (0)
Antioxidants (0)
Antiplatelets (1)
Calcium antagonists (0)
Cholinergic agents (0)
Dextran (0)
Intensive surveillance (0)
IV fluids (0)
Lipid lowering drugs (0)
Pentoxifylline (0)
Pre-operative hydration (0)
Pre-operative drugs (0)
Pre-operative factors (not drugs or hydration) (0)
Prostaglandins (0)
Temperature (0)
Thromboxane antagonists (0)
Xanthine oxidase inhibitors (0)
Venoactive agents (0)
Atherectomy of occluded bypass (0)
Thrombolysis with catheter (0)
Types of incision (0)
Lumbar sympathectomy (0)
Surgical techniques (0)
Types of sutures (0)
Stent insertion (4)
Atherectomy for peripheral arterial disease (protocol stage)
Lumbar sympathectomy (0)
Venesection (0)
Treatment of complications associated with PAOD (4)
Medical treatments (0)
Anticoagulants (0)
Antiplatelets (0)
Beta-blockers (0)
Blood pressure lowering drugs (0)
Calcium antagonists (0)
Serotonin antagonists (0)
Surgical treatments (0)
Lumbar sympathectomy (0)
Rehabilitation (0)
Thromboembolism (117)
Deep vein thrombosis (DVT) related (59)
Diagnostic Test Accuracy (0)
Prevention (41)
Medical prophylaxis (24)
Anticoagulants (12)
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Antioxidants (0)
Antithrombotics (4)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Antiplatelets (1)
Biguanides (0)
Calcium antagonists (0)
Chloroquine and derivatives (0)
Cyctotoxic/DNA reactive drugs (0)
Dextran (0)
Fibrinolytics (0)
Immunosuppressants (0)
Non-steroidal anti-inflammatories (0)
Oestrogens (0)
Pentasaccharides (3)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Polysaccharides (0)
Protease inhibitors (0)
Pentoxifylline (0)
Rheological agents (0)
Statins (0)
Steroid hormones (0)
Testosterone/anabolic steroids (0)
Vasodilators (0)
Surgical prophylaxis (0)
Anaesthetic (0)
Cement (orthopaedic surgery) (0)
Catheter material (0)
Catheter location (0)
IV fluids (0)
Risk assessment (0)
Tourniquet (0)
Physical methods of prophylaxis (17)
Compression (stockings) (8)
Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis (protocol stage)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Exercise (1)
Mechanical prophylaxis (5)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Other methods of prophylaxis (0)
Risk assessment (0)
Treatment (18)
Medical treatment (18)
Anticoagulant monitoring (1)
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Anticoagulants (11)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Antiplatelets (0)
Biguanides (0)
Method of administration (2)
Pentasaccharides (0)
Polysaccharides (0)
Proteolytic enzymes (0)
Rheological agents (0)
Surgical treatment (0)
Angioplasty (0)
Arterio-venous fistulae (0)
Filter insertion (0)
Surgical removal (0)
Thrombectomy (0)
Idiopathic recurrent vein thrombosis (0)
Prevention (0)
Physical prophylaxis (0)
Compression (0)
Treatment (0)
Antiplatelets (0)
Not DVT related (6)
Prevention (5)
Anticoagulants (3)
Non-steroidal anti-inflammatories (0)
Rehabilitation (0)
Post thrombotic syndrome (PTS) (7)
Prevention (4)
Medical prophylaxis (1)
Rutosides (1)
Rutosides for prevention of post thrombotic syndrome (protocol stage)
Treatment (3)
Medical (1)
Rutosides (1)
Rutosides for treatment of post-thrombotic syndrome (protocol stage)
Pulmonary Embolism (PE) (45)
Prevention (35)
Medical prophylaxis (26)
Anticoagulants (11)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (protocol stage)
Antithrombotics (6)
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pentasaccharides (3)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Statins (0)
Physical methods of prophylaxis (8)
Compression (stockings) (4)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Mechanical prophylaxis (4)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Treatment (10)
Medical treatment (9)
Anticoagulant monitoring (1)
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Anticoagulants (4)
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Pentasaccharides (0)
Physical treatment (0)
Thrombophilia (1)
Thrombophlebitis (12)
Cannulation phlebitis (4)
Prevention (4)
Medical prevention methods (2)
Anticoagulants (2)
Analgesics (0)
Anti-inflammatories (0)
IV fluids (0)
Steroids (0)
Physical prevention methods (2)
Duration of cannulisation (0)
Equipment - set up, and delivery systems (0)
Location of cannula (0)
Treatment (0)
Medical treatments (0)
Anticoagulants (0)
Antiplatelets (0)
Biguanides (0)
Fibrinolytics (0)
Non-steroidal anti-inflammatories (0)
Rheological agents (0)
Rutosides (0)
Sedatives (0)
Serotonin antagonists (0)
Steroids (0)
Ulcers (arterial and mixed) (2)
Prevention (0)
Treatment (2)
Medical treatments (2)
Anticoagulants (0)
Antibiotics (0)
Antiplatelets (0)
Bradykinin antagonists (0)
Calcium antagonists (0)
Cell suspensions (0)
Co-enzymes for vitamin function (0)
Energy rich phosphates (0)
Fibrinolytics (0)
Growth hormones (0)
Herbal preparations (0)
Levamisole (0)
Metabolic activators (0)
Naftidrofuryl (0)
Oygen supplementation (0)
Prostaglandins (0)
Polysaccharides (0)
Proteolytic enzymes (0)
Pentoxifylline (0)
Rheological agents (0)
Ruscus extracts (0)
Trace elements (0)
Vasodilators (0)
Venoactive agents (0)
Physical treatments (0)
Compression (eg Una's boot) (0)
Electromagnetic field therapy (0)
Electromyostimulation (0)
Phototherapy (0)
Spinal cord stimulation (0)
Ultrasound (0)
Rehabilitation (0)
Vasculitis (10)
Kawasaki disease (7)
Treatment (7)
Immunoglobulin (3)
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Salicylate (3)
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Steroid (1)
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Vasospastic disorders (Primary Raynaud's Phenomenon) (6)
Prevention (0)
Treatment (6)
Medical treatments (6)
Amino acids (0)
Alpha-agonists (0)
Alpha-blockers (0)
Adrenergic blockers (0)
Antiplatelets (0)
Beta-antagonists (0)
Beta-blockers (0)
Bradykin antagonists (0)
Buflomedil (0)
Calcium antagonists (1)
Calcium channel blockers for primary Raynaud's Phenomenon (protocol stage)
Dextran (0)
Essential fatty acids (0)
Naftidrofuryl (0)
Prostaglandins (0)
Pentoxifylline (0)
Rheological agents (0)
Thyroid hormone (0)
Topical applications (0)
Vasospastic agents (0)
Physical treatments (0)
Autogenic training (relaxation etc) (0)
Electromyelogram (0)
Temperature biofeedback (0)
Rehabilitation (0)
Varicose veins (10)
Prevention (0)
Treatment (10)
Medical treatments (0)
Analgesics (0)
Antibiotics (0)
Antiplatelets (0)
Calcium antagonists (0)
Energy rich phosphates (0)
Glucose (0)
Homeopathic remedies (0)
Ruscus extract (0)
Rutosides (0)
Topical treatments (0)
Venoactive agents (0)
Vasodilators (0)
Vasospastic agents (0)
Surgical treatments (10)
Closure techniques (0)
Rehablitation (0)
Other peripheral vascular problems including (3)
Chilblains (0)
Capillary fragility (0)
Polyarteritis nodosa (0)
Healthy volunteers testing (0)
Medical treatments (0)
Amino acids (0)
Anticoagulants (0)
ACE inhibitors (0)
Alcohol (0)
Anaesthetics (0)
Antibiotics (0)
Antioxidants (0)
Antiplatelets (0)
|